Principal Investigator: Dana van Bemmel
Funding Mechanism: Research Contract
ID number: HHSF223201300052P
Award Date: 12/20/2012
The Tobacco Control Act mandates the regulation of tobacco products using a population health standard including both users and non-users of tobacco products. To help meet this mandate, the Population Assessment of Tobacco and Health (PATH) study -- a nationally representative, longitudinal cohort study that will survey tobacco product users, never users, and former users including youth aged 12-17 and adults aged 18 and older – is gathering data on tobacco product use, attitudes, and health conditions and is collecting biological specimens (buccal cells, urine, and blood) from consenting adults. Quest Diagnostics Clinical Laboratories, a private contract laboratory that assays human biological specimens for diagnostic purposes as well as for chemical exposure, will measure human fibrinogen activity in 150 participant plasma samples. These data may inform the development of final baseline study procedures related to the collection, shipment, processing, storage, and requisitioning of biospecimens.